Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia
KANTARJIAN, Hagop M, THOMAS, Xavier G, KUO, Ching-Yuan, ORIOL, Albert, RAVANDI, Farhad, FADERL, Stefan, DELAUNAY, Jacques, LYSAK, Daniel, MINDEN, Mark, ARTHUR, Christopher, DMOSZYNSKA, Anna, WIERZBOWSKA, Agnieszka, MAZUR, Grzegorz, MAYER, Jiri, GAU, Jyh-Pyng, CHOU, Wen-Chien, BUCKSTEIN, Rena, CERMAK, Jaroslav
Published in Journal of clinical oncology (20.07.2012)
Published in Journal of clinical oncology (20.07.2012)
Get full text
Journal Article
Eradication of bone marrow minimal residual disease may prompt early treatment discontinuation in CLL
Strati, Paolo, Keating, Michael J., O’Brien, Susan M., Burger, Jan, Ferrajoli, Alessandra, Jain, Nitin, Tambaro, Francesco Paolo, Estrov, Zeev, Jorgensen, Jeffrey, Challagundla, Pramoda, Faderl, Stefan H., Wierda, William G.
Published in Blood (12.06.2014)
Published in Blood (12.06.2014)
Get full text
Journal Article
Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study
Jabbour, Elias, Dr, Kantarjian, Hagop, Prof, Ravandi, Farhad, Prof, Thomas, Deborah, Prof, Huang, Xuelin, Prof, Faderl, Stefan, Prof, Pemmaraju, Naveen, Prof, Daver, Naval, MD, Garcia-Manero, Guillermo, Prof, Sasaki, Koji, MD, Cortes, Jorge, Prof, Garris, Rebecca, Yin, C Cameron, MD, Khoury, Joseph D, MD, Jorgensen, Jeffrey, Prof, Estrov, Zeev, Prof, Bohannan, Zachary, MA, Konopleva, Marina, MD, Kadia, Tapan, MD, Jain, Nitin, MD, DiNardo, Courtney, MD, Wierda, William, Prof, Jeanis, Vicky, RN, O'Brien, Susan, Prof
Published in The lancet oncology (01.11.2015)
Published in The lancet oncology (01.11.2015)
Get full text
Journal Article
Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience
Kantarjian, Hagop, O'Brien, Susan, Jabbour, Elias, Garcia-Manero, Guillermo, Quintas-Cardama, Alfonso, Shan, Jenny, Rios, Mary Beth, Ravandi, Farhad, Faderl, Stefan, Kadia, Tapan, Borthakur, Gautam, Huang, Xuelin, Champlin, Richard, Talpaz, Moshe, Cortes, Jorge
Published in Blood (01.03.2012)
Published in Blood (01.03.2012)
Get full text
Journal Article
Inotuzumab ozogamicin, an anti-CD22–calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study
Kantarjian, Hagop, Prof, Thomas, Deborah, MD, Jorgensen, Jeffrey, MD, Jabbour, Elias, MD, Kebriaei, Partow, MD, Rytting, Michael, MD, York, Sergernne, RN, Ravandi, Farhad, MD, Kwari, Monica, RN, Faderl, Stefan, MD, Rios, Mary Beth, RN, Cortes, Jorge, MD, Fayad, Luis, MD, Tarnai, Robert, PhD, Wang, Sa A, MD, Champlin, Richard, MD, Advani, Anjali, MD, O'Brien, Susan, MD
Published in The lancet oncology (01.04.2012)
Published in The lancet oncology (01.04.2012)
Get full text
Journal Article
Effective Treatment of Acute Promyelocytic Leukemia With All-Trans-Retinoic Acid, Arsenic Trioxide, and Gemtuzumab Ozogamicin
RAVANDI, Farhad, ESTEY, Eli, FERRAJOLI, Alessandra, VERSTOVSEK, Srdan, GARCIA-MANERO, Guillermo, CORTES, Jorge, KANTARJIAN, Hagop, JONES, Dan, FADED, Stefan, O'BRIEN, Susan, FIORENTINO, Jackie, PIERCE, Sherry, BLAMBLE, Deborah, ESTROV, Zeev, WIERDA, William
Published in Journal of clinical oncology (01.02.2009)
Published in Journal of clinical oncology (01.02.2009)
Get full text
Journal Article
Phase II Study of Lenalidomide and Rituximab As Salvage Therapy for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
BADOUX, Xavier C, KEATING, Michael J, SIJIN WEN, WIERDA, William G, O'BRIEN, Susan M, PADERL, Stefan, SARGENT, Rachel, BURGER, Jan A, FERRAJOLI, Alessandra
Published in Journal of clinical oncology (10.02.2013)
Published in Journal of clinical oncology (10.02.2013)
Get full text
Journal Article
Chemoimmunotherapy With a Modified Hyper-CVAD and Rituximab Regimen Improves Outcome in De Novo Philadelphia Chromosome–Negative Precursor B-Lineage Acute Lymphoblastic Leukemia
THOMAS, Deborah A, O'BRIEN, Susan, ANDREEFF, Michael, PIERCE, Sherry, GARRIS, Rebecca, KEATING, Michael J, CORTES, Jorge, KANTARJIAN, Hagop M, FADERL, Stefan, GARCIA-MANERO, Guillermo, FERRAJOLI, Alessandra, WIERDA, William, RAVANDI, Farhad, VERSTOVSEK, Srdan, JORGENSEN, Jeffrey L, BUESO-RAMOS, Carlos
Published in Journal of clinical oncology (20.08.2010)
Published in Journal of clinical oncology (20.08.2010)
Get full text
Journal Article
Effect of Complete Remission and Responses Less Than Complete Remission on Survival in Acute Myeloid Leukemia: A Combined Eastern Cooperative Oncology Group, Southwest Oncology Group, and M. D. Anderson Cancer Center Study
Walter, Roland B, Kantarjian, Hagop M, Huang, Xuelin, Pierce, Sherry A, Sun, Zhuoxin, Gundacker, Holly M, Ravandi, Farhad, Faderl, Stefan H, Tallman, Martin S, Appelbaum, Frederick R, Estey, Elihu H
Published in Journal of clinical oncology (01.04.2010)
Published in Journal of clinical oncology (01.04.2010)
Get full text
Journal Article
Phase I/II Study of Combination Therapy With Sorafenib, Idarubicin, and Cytarabine in Younger Patients With Acute Myeloid Leukemia
RAVANDI, Farhad, CORTES, Jorge E, PIERCE, Sherry R, BRANDT, Mark, BYRD, Anna, NEBIYOU BEKELE, B, PRATZ, Keith, LUTHRA, Rajyalakshmi, LEVIS, Mark, ANDREEFF, Michael, KANTARJIAN, Hagop M, JONES, Daniel, FADERL, Stefan, GARCIA-MANERO, Guillermo, KONOPLEVA, Marina Y, O'BRIEN, Susan, ESTROV, Zeev, BORTHAKUR, Gautam, THOMAS, Deborah
Published in Journal of clinical oncology (10.04.2010)
Published in Journal of clinical oncology (10.04.2010)
Get full text
Journal Article
Randomized Open-Label Phase II Study of Decitabine in Patients With Low- or Intermediate-Risk Myelodysplastic Syndromes
GARCIA-MANERO, Guillermo, JABBOUR, Elias, NADEEM, Ahmed, KASSALOW, Laurent, KANTARJIAN, Hagop, BORTHAKUR, Gautam, FADERL, Stefan, ESTROV, Zeev, HUI YANG, MADDIPOTI, Sirisha, GODLEY, Lucy A, GABRAIL, Nashat, BERDEJA, Jesus G
Published in Journal of clinical oncology (10.07.2013)
Published in Journal of clinical oncology (10.07.2013)
Get full text
Journal Article
Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I Trial
FADERL, Stefan, WETZLER, Meir, MARIS, Michael, KOVACSOVICS, Tibor, GOLDBERG, Stuart, SEITER, Karen, HARI, Parameswaran, GREINER, Jochen, VEY, Norbert, RECHER, Christian, RAVANDI, Farhad, WANG, Eunice S, RIZZIERI, David, VASCONCELLES, Michael, HUEBNER, Dirk, KANTARJIAN, Hagop M, SCHILLER, Gary, JAGASIA, Madan, STUART, Robert, GANGULY, Siddhartha, AVIGAN, David, CRAIG, Michael, COLLINS, Robert
Published in Journal of clinical oncology (10.07.2012)
Published in Journal of clinical oncology (10.07.2012)
Get full text
Journal Article
Efficacy and safety of CPX-351 versus 7 + 3 chemotherapy by European LeukemiaNet 2017 risk subgroups in older adults with newly diagnosed, high-risk/secondary AML: post hoc analysis of a randomized, phase 3 trial
Cortes, Jorge E, Lin, Tara L, Asubonteng, Kobby, Faderl, Stefan, Lancet, Jeffrey E, Prebet, Thomas
Published in Journal of hematology and oncology (26.10.2022)
Published in Journal of hematology and oncology (26.10.2022)
Get full text
Journal Article
An oral fixed-dose combination of decitabine and cedazuridine in myelodysplastic syndromes: a multicentre, open-label, dose-escalation, phase 1 study
Savona, Michael R, Odenike, Olatoyosi, Amrein, Philip C, Steensma, David P, DeZern, Amy E, Michaelis, Laura C, Faderl, Stefan, Harb, Wael, Kantarjian, Hagop, Lowder, James, Oganesian, Aram, Azab, Mohammad, Garcia-Manero, Guillermo
Published in The Lancet. Haematology (01.04.2019)
Published in The Lancet. Haematology (01.04.2019)
Get more information
Journal Article
Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia
Kantarjian, Hagop, Oki, Yasuhiro, Garcia-Manero, Guillermo, Huang, Xuelin, O'Brien, Susan, Cortes, Jorge, Faderl, Stefan, Bueso-Ramos, Carlos, Ravandi, Farhad, Estrov, Zeev, Ferrajoli, Alessandra, Wierda, William, Shan, Jianqin, Davis, Jan, Giles, Francis, Saba, Hussain I., Issa, Jean-Pierre J.
Published in Blood (01.01.2007)
Published in Blood (01.01.2007)
Get full text
Journal Article
Phase II Trial of Vorinostat With Idarubicin and Cytarabine for Patients With Newly Diagnosed Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Garcia-Manero, Guillermo, Tambaro, Francesco Paolo, Bekele, Nebiyou B, Yang, Hui, Ravandi, Farhad, Jabbour, Elias, Borthakur, Gautam, Kadia, Tapan M, Konopleva, Marina Y, Faderl, Stefan, Cortes, Jorge E, Brandt, Mark, Hu, Yumin, McCue, Deborah, Newsome, Willie Mae, Pierce, Sherry R, de Lima, Marcos, Kantarjian, Hagop M
Published in Journal of clinical oncology (20.06.2012)
Published in Journal of clinical oncology (20.06.2012)
Get full text
Journal Article
Preclinical and Early Clinical Evaluation of the Oral AKT Inhibitor, MK-2206, for the Treatment of Acute Myelogenous Leukemia
KONOPLEVA, Marina Y, WALTER, Roland B, HONGBO LU, DEBOSE, Lakiesha, BURGER, Jan A, ANDREEFF, Michael, WENBIN LIU, BAGGERLY, Keith A, KORNBLAU, Steven M, DOYLE, L. Austin, ESTEY, Elihu H, KANTARJIAN, Hagop M, FADERL, Stefan H, JABBOUR, Elias J, ZHIHONG ZENG, BORTHAKUR, Gautam, XUELIN HUANG, KADIA, Tapan M, RUVOLO, Peter P, FELIU, Jennie B
Published in Clinical cancer research (15.04.2014)
Published in Clinical cancer research (15.04.2014)
Get full text
Journal Article
Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia
KEATING, Michael J, O'BRIEN, Susan, KOLLER, Charles, WIERDA, William, DETRY, Michelle A, LYNN, Alice, KANTARJIAN, Hagop, ALBITAR, Maher, LERNER, Susan, PLUNKETT, William, GILES, Francis, ANDREEFF, Michael, CORTES, Jorge, FADERL, Stefan, THOMAS, Deborah
Published in Journal of clinical oncology (20.06.2005)
Published in Journal of clinical oncology (20.06.2005)
Get full text
Journal Article